"With the first finalist now confirmed and me hoping England secure the second spot tonight, we're reaching the business end of the Football World Cup. Throughout the tournament, the competition has reminded me of another interest of mine: tracking the evolution of the obesity space. Just as the expanded World Cup has brought more teams into contention, the obesity market is attracting an ever-growing number of competitors. The question, however, is whether we're seeing genuine diversity of approach or simply more players running variations of the same game plan. It raises an interesting question for the pharmaceutical industry: how are organisations building their pipelines for the "Obesity World Cup"? As companies compete for a share of this rapidly growing market, are we witnessing a true treatment revolution, or a race to develop increasingly similar assets against an established playbook?" Jordan Lee, our consultant is keeping a close eye on competitor strategy on an off the pitch? Do you agree with his thoughts? Tell us below. #Obesity #GLP1 #DrugDevelopment #Pharma #Biotech #MetabolicHealth #HealthcareInnovation
Cambridge Healthcare Research
Business Consulting and Services
Giving our clients the power of knowing | Specialist intelligence and research services in healthcare and life sciences
About us
We're Cambridge Healthcare Research, the trusted partner for every healthcare decision maker. About CHR We embed our curious and considered teams at the heart of any challenge faced by decision makers in healthcare and life sciences. Through unrivalled understanding, we give our partners the power of knowing that no matter their next step, it's well-informed with critical insights that support pivotal judgements. Employing over 130 exceptional individuals, our entrepreneurial spirit has led to the development of specialist intelligence and research services. As we have grown, so has our vision – to be the organisation that helps the brightest ideas reach patients. What we do We help our clients make strategic decisions. Our consulting expertise spans product strategy and commercialisation in the pharmaceutical, biotechnology, medical device and life-science sectors. Learn more about our strategic competitive intelligence division - Solici, by visiting solici.com, or visiting www.linkedin.com/company/solici Learn more about market research division - Vox.Bio, by visiting www.vox.bio, or visiting www.linkedin.com/company/voxbio-market-research Work at CHR Our culture nurtures the talented and the curious, helping the inquisitive and the ambitious to develop. With our head office in London, as well as the option to work remotely, our people can benefit from a hybrid working model that balances work and life. Supporting our teams with the power of knowing, we offer events and training across all our brands. We promote positive social impact, develop practical skills and offer expert advice, positively challenging each other to be the best we can be for ourselves and our clients. Our contributions to society go further than just helping the brightest ideas reach patients. That’s why we've developed CHR for Society – helping our team make a positive impact in the world.
- Website
-
http://www.camhcr.com
External link for Cambridge Healthcare Research
- Industry
- Business Consulting and Services
- Company size
- 51-200 employees
- Headquarters
- Cambridge
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Development Landscapes, Opportunity Assessments, Product Evaluation and Benchmarking, Player Characterisation, Forecasting, Investment Support, Therapy Area analysis , Pharma Research, Market Research, and Landscape mapping
Locations
-
Primary
Get directions
St John's Innovation Centre
Cambridge, CB4 0WS, GB
-
Get directions
127 Cheapside
London, England, GB
-
Get directions
607, Ruiguang Rd.
Taipei City, Taiwan 11492, TW
-
Get directions
San Diego, California 92103, US
Employees at Cambridge Healthcare Research
Updates
-
From the excitement of Sunday's match to the highly anticipated impact of obesity medication in the UK market, we ask "What counts as winning when it comes to obesity care? "🥅 🏆 Jordan Lee, our consultant with an eye on obesity, looks at obesity pipelines through a World Cup lens. By comparing big players - Novo Nordisk, Eli Lilly, Amgen, Pfizer, Roche, and AstraZeneca, to an equivalent national team what, can we learn about their competitive position, squad depth, or style of play? Read the article below and tells us what you think. #Obesity #GLP1 #DrugDevelopment #Pharma #Biotech #MetabolicHealth #HealthcareInnovation #WorldCup #Tournament
What counts as winning when it comes to obesity care? 🥅 🏆 The obesity market has more contenders than ever, but many are still playing from the same tactical playbook. Our consultant Jordan Lee uses the 2026 World Cup as a lens. Examining how leading companies are building their obesity pipelines, where their strategies differ, and whether the field is judging success by too narrow a scoreboard. ⚽ #Obesity #GLP1 #DrugDevelopment #Pharma #Biotech #MetabolicHealth #HealthcareInnovation #CambridgeHealthcareResearch
-
Jordan Lee, our Senior Consultant, tells us why yesterday's decision to make oral Wegovy available in the UK, carries weight. #Obesity #GLP1 #OralGLP1 #WeightManagement #ObesityCare #PharmaStrategy #HealthcareStrategy #DigitalHealth #Telehealth #UKHealthcare #NovoNordisk #EliLilly #Wegovy #Wegovyinapill
Yesterday we saw a significant moment in weight-loss medication for the UK. Oral Wegovy, has been approved for the UK market, a moment that could mark a new phase for obesity treatment. #Obesity #GLP1 #OralGLP1 #WeightManagement #ObesityCare #PharmaStrategy #HealthcareStrategy #DigitalHealth #Telehealth #UKHealthcare #NovoNordisk #EliLilly #Wegovy #Wegovyinapill
-
Our Competitive Intelligence specialists at Solici envision a possible future for nAMD gene therapy. Priya Sood, Georgie Alexandrou and Anamika Ghosh, PhD share a new perspective. #GeneTherapy #wetAMD #opthalmology #Solici #lifesciences #consulting #CompetitiveIntelligence
Revisiting gene therapy for Neovascular Age-Related Macular Degeneration, are we ready to leave intravitreal injections behind? Read our thoughts in this refreshed article authored by Priya Sood, Georgie Alexandrou and Anamika Ghosh, PhD. Do you agree with where nAMD is heading, let us know in the comments👍 #GeneTherapy #wetAMD #nAMD #opthalmology #CHR #CambridgeHealthcareReasearch #Solici #lifesciences #consulting #pharmacology #healthcare
-
What are the UK’s top consulting firms in the Healthcare and NHS sector? We assessed over 500 firms, these are the leading players » https://lnkd.in/eGv2Q6MP
-
-
Cambridge Healthcare Research reposted this
Only 2 days to go until Pharma CI Conference USA 2025, and the Solici team is ready to hit the ground running. We’re heading to Newark with a clear mission: to connect, collaborate, and contribute to the evolving conversations in pharma and competitive intelligence. From market clarity to commercial strategy, we’re here to exchange ideas that move the needle. Planning to be there too? Come see us. Whether you're driving innovation, navigating competitive landscapes, or exploring new partnership opportunities, we’re ready to talk. Reach out to our team attending to book a meeting or just swing by the booth and say hello. Jeanne Penn Peter Donachie Benjamin Davis #PharmaCIUSA #PharmaIntelligence #CompetitiveIntelligence #PharmaInnovation #LifeSciences #Solici
-